论文部分内容阅读
目的:观察乙哌立松对顽固性呃逆的疗效及安全性。方法: 126例顽固性呃逆病人分为2组,其中治疗组66例(男性36例,女性30例)采用乙哌立松治疗。最小剂量50mg, tid,最大剂量100mg,tid。对照组60例(男性32例,女性28例),采用甲氧氯普胺、硝苯地平、东莨菪碱、氯丙嗪常规治疗。结果:治疗组总有效率92 %,对照组总有效率67 %,2组疗效比较差异有非常显著意义(P<0. 01)。治疗组服药d1起效率53 %,对照组为32% (P<0. 05)。治疗组疗程明显缩短,不良反应小。结论:乙哌立松对顽固性呃逆的治疗安全、有效。
Objective: To observe the efficacy and safety of Eperisone on refractory hiccups. Methods: 126 cases of refractory hiccup patients were divided into two groups, of which 66 cases (36 males and 30 females) were treated with Eperisone. The minimum dose of 50mg, tid, the maximum dose of 100mg, tid. Control group of 60 patients (32 males and 28 females), metoclopramide, nifedipine, scopolamine, chlorpromazine conventional treatment. Results: The total effective rate was 92% in the treatment group and 67% in the control group, with significant difference between the two groups (P <0.01). Treatment group d1 53% efficiency of the medication, the control group was 32% (P <0. 05). Treatment group significantly shorter course of treatment, adverse reactions. Conclusion: Eperisone treatment of intractable hiccups safe and effective.